Else Nutrition Announces CSE Conditional Approval

Executive Summary

• Else Nutrition Holdings Inc. has received conditional approval to list its common shares on the Canadian Securities Exchange (CSE), with a targeted trading date of July 7, 2026.
• The listing is contingent upon the completion of a US$310,000 funding round with Lind Global Fund III LP, the settlement of $207,000 in debt via share issuance, and a 10-for-1 share consolidation.
• The company will settle existing debt by issuing common shares at a post-consolidated price of $0.15 per share as part of the listing requirements.

Key Details

• Listing Approval: Received conditional approval from the Canadian Securities Exchange (CSE) for common share listing.
• Target Trading Date: July 7, 2026, subject to final filings, financing completion, debt settlement, and share consolidation.
• Financing: Working to complete an additional funding of US$310,000 with Lind Global Fund III LP.
• Share Consolidation: A 10-for-1 share consolidation will be executed (10 existing shares for each 1 new share).
• Debt Settlement: The Company will settle $207,000 of debt by issuing common shares at a post-consolidated price of $0.15 per share.
• Listing Conditions: Listing remains subject to CSE approval and satisfaction of customary listing conditions; no assurance that listing will be obtained.
• Ticker Symbols: TSX: BABY, OTCQX: BABYF, FSE: 0YL.

Notable Quotes

• No direct quotes from management were included in the provided text.